WASHINGTON, United States (AFP) — US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus. The trials will involve a total of 600 adults — half of whom have already received two doses of Moderna’s Covid-19 vaccine at least six months ago, and half of whom have received two doses plus the previously authorized booster dose. […]